Unexpected events last month re-energized two key policy debates. In early May, a leaked draft opinion by Justice Samuel Alito showed that the Supreme Court is poised to overturn Roe v. Wade in its decision of Dobbs v....more
6/1/2022
/ America Competes Act ,
BsUFA ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Climate Change ,
Department of Health and Human Services (HHS) ,
Infrastructure Investment and Jobs Act (IIJA) ,
Medicaid ,
Medical Device User Fee Program (MDUFA IV) ,
National Institute of Health (NIH) ,
PDUFA ,
Primary Elections ,
Public Health Emergency ,
Regulatory Agenda ,
Roe v Wade ,
SAMHSA ,
SCOTUS ,
Semiconductors
The Trump Administration has prioritized the elimination of overreaching regulations: In FY 2017, the Trump Administration reduced lifetime net regulatory costs across all agencies by $8.1 billion ($570 million per year)....more
12/12/2018
/ Accounting ,
Administrative Procedure Act ,
Department of Health and Human Services (HHS) ,
Disclosure Requirements ,
Electronic Medical Records ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Reform ,
HITECH Act ,
Regulatory Agenda ,
Trump Administration
Here are some key health care policy headlines from the past week that you may have missed.
Congress -
Legislation and Committee Activity -
Bloomberg: Opioids Compromise Already in the Works in Congress – Congress is...more
9/27/2018
/ Acts of Congress ,
Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Gag Clauses ,
HELP ,
OMB ,
Opioid ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Agenda ,
Telemedicine ,
Trump Administration
Congress is back in session after the August recess and, as expected, a flurry of activity took place. Here are some key health care policy headlines from the past week that you may have missed....more
9/13/2018
/ Acts of Congress ,
Affordable Care Act ,
Drug Pricing ,
HELP ,
HRSA ,
Opioid ,
Pharmacy Benefit Manager (PBM) ,
Primary Elections ,
Regulatory Agenda ,
Section 340B ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our second “Public Policy Weekly* Health Care Newsletter” in which we compile the latest health care policy news and legislation.
Please...more
5/14/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
DEA ,
Department of Health and Human Services (HHS) ,
Department of Veterans Affairs ,
Drug Pricing ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare Part C ,
Mental Health ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda ,
Section 340B ,
Social Security Act ,
Trade Policy ,
Trump Administration